NCT07704099 — "Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy" trial site landscape

Public-registry site landscape for NCT07704099, “Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy”, a Duchenne Muscular Dystrophy study sponsored by Keros Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07704099 (registry record)
Study title	Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Official title	A Multicenter, Phase 2, Open-Label Study Evaluating the Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Sponsor	Keros Therapeutics, Inc.
Condition(s)	Duchenne Muscular Dystrophy
Phase	PHASE2
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07704099.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07704099 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Duchenne Muscular Dystrophy trials

← Eichor home · All tracked trials · Duchenne Muscular Dystrophy studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →